Tovorafenib Impurity 13 | CAS 6633-61-0 - Request Quote
Tovorafenib Impurity 13
| SZ CAT No: | SZ-T202018 |
| CAS No | 6633-61-0 |
| Mol.F. | C5H6N2O2S |
| Mol.Wt. | 158.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 726185-57-5 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tovorafenib Impurity 13 is chemically Methyl 2-aminothiazole-5-carboxylate. Tovorafenib Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Tovorafenib Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tovorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 6633-61-0
Purchase 6633-61-0
Order 6633-61-0
Enquire 6633-61-0
price of 6633-61-0
6633-61-0 Supplier
6633-61-0 Manufacturer
6633-61-0 Exporter
buy high quality Tovorafenib Impurity 13
Purchase Tovorafenib Impurity 13
Tovorafenib Impurity 13 suppliers
Tovorafenib Impurity 13 manufacturers
Tovorafenib Impurity 13 price
Order Tovorafenib Impurity 13
Enquire Tovorafenib Impurity 13
Tovorafenib Impurity 13 cost
Tovorafenib Impurity 13 Supplier
Tovorafenib Impurity 13 Distributor
Tovorafenib Impurity 13 for Method Validation
Tovorafenib Reference Standard
Tovorafenib Impurity 13 for ANDA Filing
Tovorafenib Impurity 13 for Forced Degradation Studies
Tovorafenib Impurity 13 Identification Standards
Tovorafenib Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


